Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2018
Jan. 31, 2017
Jan. 31, 2016
Cash flows from operating activities:      
Net income (loss) $ 13,498 $ (71,249) $ (47,697)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization of property and equipment 2,273 2,953 3,380
(Recovery on) provision for loss contract (593) (4,118) 9,162
Amortization of intangible assets 2,423 3,302 4,780
Provision for bad debts 79 597 58
Stock-based compensation expense 2,696 2,621 3,552
Deferred income taxes (14,132) 14,676 (985)
(Gain) loss on investment in affiliates (2,555) 500 31
Loss on impairment of long-lived assets   23,772 21,464
Other 398 621 108
Changes in operating assets and liabilities, excluding impact of acquisitions:      
Accounts receivable 5,132 42 (1,721)
Unbilled receivables 3,968 4,694 (4,359)
Inventories 34 806 (937)
Prepaid expenses and other assets (588) 1,378 (1,097)
Accounts payable (2,499) (1,674) 874
Accrued expenses 3,505 (4,872) (2,712)
Deferred revenues (1,078) (2,417) (1,431)
Other operating activities 386 30 (1,132)
Total cash provided by (used in) operating activities 12,947 (28,338) (18,662)
Cash flows from investing activities:      
Purchases of property and equipment (526) (683) (1,397)
Investment in capitalized software     (2,440)
Purchases of marketable securities (7,246) (2,008) (9,033)
Proceeds from sale and maturity of marketable securities 8,992 4,005 11,043
Proceeds from sale of investment in affiliates 4,555   464
Acquisition of businesses and payment of contingent consideration, net of cash acquired   (5,243) (11,686)
Other investing activities 236 57 3
Total cash provided by (used in) investing activities 6,011 (3,872) (13,046)
Cash flows from financing activities:      
Proceeds from issuance of common stock 54 60 193
Payments of withholding tax on RSU vesting (141) (183) (1)
Total cash (used in) provided by financing activities (87) (123) 192
Effect of exchange rate changes on cash, cash equivalents and restricted cash (3,621) 1,929 312
Net increase (decrease) in cash, cash equivalents and restricted cash 15,250 (30,404) (31,204)
Cash, cash equivalents and restricted cash, beginning of period 28,411 58,815 90,019
Cash, cash equivalents and restricted cash, end of period 43,661 28,411 58,815
Supplemental disclosure of cash flow information:      
Income taxes paid $ 368 178 640
Interest paid   6 6
Supplemental disclosure of non-cash investing and financing activities:      
Transfer of items originally classified as inventories to equipment   24 532
DCC Labs [Member]      
Supplemental disclosure of non-cash investing and financing activities:      
Fair value of common stock issued for acquisition   2,640  
Timeline Labs [Member]      
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Loss on impairment of long-lived assets     21,900
Supplemental disclosure of non-cash investing and financing activities:      
Fair value of common stock issued for acquisition     3,019
Common Stock [Member]      
Supplemental disclosure of non-cash investing and financing activities:      
Fair value of common stock issued for deferred stock consideration obligation   $ 3,452 $ 1,754